Australian research, Date: 2021, Original research
Date: 2021
Citation: Nguyen AD, Baysari MT, Duong M, Zheng WY, Ng B, Lo S, Robinson F, Hilmer SN. Communicating deprescribing decisions made in hospital with general practitioners in the community: a qualitative study. Internal Medicine Journal. 2021 Jan 19.
Link: doi.org/10.1111/imj.15208
Date: 2021, Original research, Research
Date: 2021
Citation: Weir, Kristie Rebecca, et al. “The role of older patients’ goals in GP decision-making about medicines: a qualitative study.” BMC Family Practice 22.1 (2021): 1-12.
Link: https://doi.org/10.1186/s12875-020-01347-y
2015-2019, Original research, Research
Date: 2019
Citation: Ailabouni, N., Mangin, D. & Nishtala, P.S. DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities. Int J Clin Pharm 41, 167–178 (2019)
Link: doi.org/10.1007/s11096-019-00784-9
2015-2019, Australian research, Original research, Research
Date: 2019
Citation: Weir, Kristie Rebecca, et al. “Pharmacists and patients sharing decisions about medicines: Development and feasibility of a conversation guide.” Research in Social and Administrative Pharmacy 15.6 (2019): 682-690.
Link: https://doi.org/10.1016/j.sapharm.2018.08.009
2015-2019, Research, Review
Date: 2017
Citation: Reeve, Emily, Wade Thompson, and Barbara Farrell. “Deprescribing: a narrative review of the evidence and practical recommendations for recognizing opportunities and taking action.” European Journal of Internal Medicine 38 (2017): 3-11.
Link: https://doi.org/10.1016/j.ejim.2016.12.021